Clinical Trial Update: Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating CS-3150 in combination with an ARB or ACE inhibitor for hypertension in patients with moderate renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Renal Impairment

Drugs mentioned

• ARB or ACE inhibitor
• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Hypertension With Moderate Renal Impairment | Phase 3 | Status: COMPLETED